封面
市場調查報告書
商品編碼
1734883

2032 年乳酸菌菌株市場預測:按類型、形態、最終用戶和地區進行的全球分析

Lactobacillus Strains Market Forecasts to 2032 - Global Analysis By Type, Form, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預測期內全球乳酸菌菌株市場以 7.2% 的複合年成長率成長。

乳酸桿菌菌株是一種有益菌,常見於Kefir、德國酸菜和優格等發酵食品以及人體腸道。這些益生菌能夠增強免疫系統,抑制有害病原體的生長,並平衡腸道菌群,對維持消化器官系統健康至關重要。包括嗜酸乳桿菌、鼠李糖乳桿菌和乾酪乳桿菌在內的各種菌株都具有特殊特性,可提供各種健康益處,例如全面支持免疫功能、改善乳糖消化和減輕胃腸不適。此外,由於其在促進腸道健康和預防某些感染疾病方面的治療潛力,它們擴大被用於膳食補充劑和機能性食品中。

根據美國衛生研究院(NIH)的數據,約有390萬人(佔成年人口的1.6%)使用益生菌作為維護健康的一部分,其中乳酸桿菌菌株是最常服用的益生菌之一。

提高消費者對腸道健康的認知

消費者越來越意識到健康的腸道菌叢對維持整體健康的重要性。科學文獻、健康影響者和醫學專家指出,益生菌對免疫調節和消化器官系統平衡至關重要,這進一步增強了消費者的這種意識。乳酸桿菌菌株因其在預防腹瀉、增強營養吸收和減少腹脹方面的公認益處而廣受歡迎。此外,這些益生菌正透過補充劑和機能性食品積極地融入人們的日常飲食中,這推動了國際市場的穩定需求。

缺乏針對特定菌株的監管和標準化

儘管許多益生菌產品聲稱含有乳酸桿菌菌株,但其功效、適應症和效果往往不一致。不同地區的法律規範差異很大,並非所有國家都要求對特定菌株的健康聲明進行臨床檢驗。這導致全球益生菌標準缺乏統一性,給消費者帶來困惑。此外,缺乏針對特定菌株用途的鑑定和劑量指南,可能會損害消費者的信任,並限制科學先進配方的商業化。

益生菌物質的創造

藥用級益生菌研發的投資正在不斷增加,乳酸桿菌菌株不僅作為膳食補充劑銷售,還作為輔助治療劑銷售,包括用於治療細菌性陰道炎、發炎性腸道疾病(IBD) 和抗生素相關性腹瀉。此外,處方益生菌的出現以及證實菌株特異性功效的臨床研究,為希望利用乳酸桿菌菌株治療潛力的製藥和生物技術公司開闢了新的收益來源。

價格壓力大,市場競爭激烈

從跨國公司到本土補充劑品牌,眾多參與者的加入使得益生菌市場(包括乳酸菌菌株)競爭異常激烈。這導致了價格戰,尤其是在機能性食品和營養保健品行業。當品牌在價格而非品質和創新上競爭時,商品化就會出現,這會削弱菌株特定好處的獨特價值。此外,零售連鎖店中的自有品牌產品進一步削弱了高階製造商的定價能力,從而降低了其長期生存能力和盈利。

COVID-19的影響:

新冠疫情對乳酸菌市場產生了多方面的影響。由於消費者對免疫和腸道健康的關注度顯著提升,益生菌補充劑和含有乳酸菌的機能性食品的需求旺盛。疫情期間,超過43%服用補充劑的美國人增加了免疫支持產品的消費,從而提振了短期銷售。然而,市場也面臨供應鏈中斷、原料取得受限以及生產和分銷延遲等挑戰,尤其是對於需要冷藏的益生菌產品。此外,產品核可和臨床試驗也受到監管延遲的影響,這在一定程度上抑制了創新。

預計乳酸菌細分市場在預測期內將佔據最大佔有率

預計乳酸菌細分市場將在預測期內佔據最大市場佔有率。這種優勢可歸因於其在藥品、發酵乳製品和膳食補充劑中的廣泛應用,因為已被證實具有增強免疫力、促進腸道健康和幫助乳糖消化等益處。嗜酸乳桿菌是研究最多的益生菌菌株之一,它通常包含在多菌株配方中,並以其穩定性和與其他有益菌的兼容性而聞名。此外,嗜酸乳桿菌強大的臨床檢驗和適應性確保了其在成熟市場和新興市場的益生菌市場中持續佔據主導地位。

預計在預測期內,液體部分將以最高的複合年成長率成長。

預計液體益生菌市場將在預測期內實現最高成長率。這一成長主要源於對易飲用、高效益生菌補充劑日益成長的需求。由於生物利用度更高、攝取更方便,液體製劑尤其受到老年人和兒童的青睞。液體製劑也常用於動物飼料,有助於解釋該市場的快速成長。此外,隨著消費者偏好轉向更容易取得、功效更強的益生菌產品,液體市場預計將大幅成長。

佔比最大的地區:

預計亞太地區將在預測期內佔據最大的市場佔有率。這一領先地位的形成得益於許多因素,包括豐富的發酵食品文化遺產、日益增強的健康意識以及中國和印度等國人口的快速成長。富含益生菌的食品(如Kefir、泡菜和優格)日益普及,以及人們對其有益腸道健康的認知不斷提高,顯著增加了對乳酸菌產品的需求。此外,亞太地區是市場擴張的主要驅動力,該地區的本地生產商正在利用這一趨勢,推出尖端的益生菌配方。

複合年成長率最高的地區:

預計北美地區在預測期內將出現最高的複合年成長率,這得益於注重健康的消費者數量增加以及人們對免疫和腸道健康益處的認知不斷加深。機能性食品的需求顯著成長,尤其是在千禧世代和老年人群體中,他們尋求預防性保健,這推動了這一成長。此外,該地區強大的醫療保健體系和良好的法規環境也進一步支持了乳酸菌菌株市場的成長。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一:

  • 公司簡介
    • 全面分析其他市場參與者(最多 3 家公司)
    • 主要企業的SWOT分析(最多3家公司)
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究資訊來源
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球乳酸菌菌株市場(按類型)

  • 嗜酸乳桿菌
  • 乾酪乳桿菌
  • 植物乳桿菌
  • 鼠李糖乳桿菌
  • 其他類型

6. 全球乳酸菌菌株市場(依型態)

  • 粉末
  • 膠囊
  • 液體
  • 冷凍乾燥
  • 藥片

7. 全球乳酸菌菌株市場(依最終用戶)

  • 機能性食品和飲料
    • 乳製品飲料
    • 非乳製品飲料
  • 嬰兒奶粉
  • 其他最終用戶

8. 全球乳酸菌菌株市場(按地區)

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • Morinaga Milk Industry Co., Ltd.
  • Chr. Hansen Holding A/S
  • Danone SA
  • ADM(Archer-Daniels-Midland Company)
  • Nestle SA
  • Koninklijke DSM NV
  • International Flavors & Fragrances Inc.
  • Arla Foods Inc
  • Lallemand Inc.
  • Yakult Honsha Co., Ltd.
  • DowDuPont
  • Chobani LLC
  • Kerry Inc
  • Post Holdings Inc
  • Novozymes Inc
Product Code: SMRC29520

According to Stratistics MRC, the Global Lactobacillus Strains Market is growing at a CAGR of 7.2% during the forecast period. Lactobacillus strains are a type of good bacteria that are frequently found in fermented foods like kefir, sauerkraut, and yogurt as well as in the human gut. By strengthening the immune system, preventing the growth of dangerous pathogens, and balancing the gut microbiota, these probiotic microbes are essential for preserving digestive health. Different strains, including Lactobacillus acidophilus, Lactobacillus rhamnosus, and Lactobacillus casei, have special qualities that support immune function overall, improve lactose digestion, and lessen gastrointestinal discomfort, among other health benefits. Moreover, their therapeutic potential in promoting gut health and preventing certain infections has led to an increasing exploration of their use in dietary supplements and functional foods.

According to data from the National Institutes of Health (NIH), probiotics are indeed used by approximately 3.9 million U.S. adults, which account for 1.6% of the adult population, as part of their wellness routines. Lactobacillus strains are among the most commonly consumed probiotics.

Market Dynamics:

Driver:

Growing awareness of gut health among consumers

The significance of a healthy gut microbiota in preserving general wellness is becoming more widely acknowledged by consumers. Scientific publications, health influencers, and medical professionals who advocate probiotics as crucial for immune modulation and digestive balance are driving this awareness. The well-established advantages of Lactobacillus strains, in particular, like preventing diarrhea, promoting nutrient absorption, and lessening bloating, have made them popular. Moreover, these probiotics are therefore being actively added to people's daily diets through supplements and functional foods, which is driving steady demand in international markets.

Restraint:

Absence of strain-specific regulation and standardization

Despite the fact that many probiotic products make the claim to contain Lactobacillus strains, labeling, potency, and efficacy are frequently inconsistent. There are significant regional differences in regulatory frameworks, and not all nations require clinical validation for health claims pertaining to particular strains. This prevents probiotic standards from being harmonized globally and causes consumers to become confused. Furthermore, if strain-specific applications lack required identification and dosage guidelines, consumer confidence may be damaged, and the commercialization of scientifically advanced formulations may be restricted.

Opportunity:

Creation of probiotic substances

Investment in the creation of pharmaceutical-grade probiotics is rising, and Lactobacillus strains are being marketed as supplements to medical treatments as well as dietary supplements. Treatments for bacterial vaginosis, inflammatory bowel disease (IBD), antibiotic-associated diarrhea, and other conditions are among them. Moreover, the emergence of prescription probiotics and clinical studies confirming strain-specific effects opens up new revenue streams for pharmaceutical and biotech companies hoping to leverage Lactobacillus strains' therapeutic potential.

Threat:

High levels of price pressure and market competition

The introduction of many players, from global firms to local supplement brands, has made the probiotic market-which includes Lactobacillus strains-extremely competitive. There are now price wars as a result, especially in the functional food and dietary supplement industries. The distinctive value of strain-specific benefits may be diminished as a result of commoditization, which occurs when brands compete on price rather than quality or innovation. Furthermore, private-label goods in retail chains further weaken premium manufacturers' pricing power, reducing their long-term viability and profitability.

Covid-19 Impact:

The COVID-19 pandemic affected the market for Lactobacillus strains in a variety of ways. Probiotic supplements and functional foods that contain Lactobacillus strains are in high demand as a result of the substantial increase in consumer awareness of immunity and gut health. During the pandemic, more than 43 percent of Americans who take supplements increased their consumption of immune-supporting products, which increased short-term sales. But the market also had to contend with issues like disruptions in the supply chain, restricted access to raw materials, and production and distribution delays, especially for probiotic products that were refrigerated. Additionally, product approvals and clinical trials were impacted by regulatory slowdowns, which somewhat inhibited innovation.

The lactobacillus acidophilus segment is expected to be the largest during the forecast period

The lactobacillus acidophilus segment is expected to account for the largest market share during the forecast period. This dominance is ascribed to its extensive use in pharmaceuticals, fermented dairy products, and dietary supplements because of its proven advantages in enhancing immunity, promoting gut health, and facilitating lactose digestion. One of the most studied probiotic strains is Lactobacillus acidophilus, which is frequently found in multistrain formulations and is known for its stability and compatibility with other good bacteria. Moreover, Lactobacillus acidophilus's strong clinical validation and adaptability guarantee its sustained dominance in both established and developing probiotic markets.

The liquid segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the liquid segment is predicted to witness the highest growth rate. This expansion is mostly due to the growing need for easy-to-take and efficient probiotic supplements. Due to their improved bioavailability and ease of consumption, liquid formulations are especially well-liked by older adults and children. The liquid form is also frequently used in animal feed, which helps explain its quick market growth. Additionally, the liquid market is expected to grow significantly as consumer preferences change toward more readily available and powerful probiotic options, which will be in line with larger trends in health and wellness.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Numerous factors, such as a rich cultural legacy of fermented foods, increased health consciousness, and a rapidly expanding population in nations like China and India, are contributing to this leadership. The demand for Lactobacillus-based products has increased significantly as a result of the growing popularity of probiotic-rich foods like kefir, kimchi, and yogurt as well as growing awareness of the advantages for gut health. Furthermore, Asia Pacific is becoming a major force behind market expansion as local producers in the area are leveraging this trend by launching cutting-edge probiotic formulations.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by a rise in health-conscious consumers and growing knowledge of the advantages of immunity and gut health. The demand for functional foods has significantly increased, especially among millennials and older populations looking for preventive wellness options, which is driving this growth. Moreover, the market growth for Lactobacillus strains is further supported by the region's strong healthcare system and advantageous regulatory environment.

Key players in the market

Some of the key players in Lactobacillus Strains Market include Morinaga Milk Industry Co., Ltd., Chr. Hansen Holding A/S, Danone S.A, ADM (Archer-Daniels-Midland Company), Nestle S.A, Koninklijke DSM N.V., International Flavors & Fragrances Inc., Arla Foods Inc, Lallemand Inc., Yakult Honsha Co., Ltd., DowDuPont, Chobani LLC, Kerry Inc, Post Holdings Inc and Novozymes Inc.

Key Developments:

In September 2024, Nestle is to build its first food factory in Saudi Arabia after signing a contract commiting to the project. The Saudi Press Agency, the country's state news agency, reported that Nestle has signed up for a 117,000 sq m plot in Jeddah's Third Industrial City.

In January 2024, French food group Danone said that it had signed an agreement to sell its premium organic dairy units in the United States to investment firm Platinum Equity. The sale of the Horizon Organic and Wallaby businesses is part of the company's portfolio review and asset rotation program the company announced in March 2022, Danone said in a statement, without disclosing the financial details of the deal.

In December 2023, Kerry Group plc announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S and Novozymes A/S on a carve out basis. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

Types Covered:

  • Lactobacillus Acidophilus
  • Lactobacillus Casei
  • Lactobacillus Plantarum
  • Lactobacillus Rhamnosus
  • Other Types

Forms Covered:

  • Powder
  • Capsules
  • Liquid
  • Freeze-dried
  • Tablets

End Users Covered:

  • Functional Food & Beverages
  • Infant Formula
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lactobacillus Strains Market, By Type

  • 5.1 Introduction
  • 5.2 Lactobacillus Acidophilus
  • 5.3 Lactobacillus Casei
  • 5.4 Lactobacillus Plantarum
  • 5.5 Lactobacillus Rhamnosus
  • 5.6 Other Types

6 Global Lactobacillus Strains Market, By Form

  • 6.1 Introduction
  • 6.2 Powder
  • 6.3 Capsules
  • 6.4 Liquid
  • 6.5 Freeze-dried
  • 6.6 Tablets

7 Global Lactobacillus Strains Market, By End User

  • 7.1 Introduction
  • 7.2 Functional Food & Beverages
    • 7.2.1 Dairy Beverages
    • 7.2.2 Non-dairy Beverages
  • 7.3 Infant Formula
  • 7.4 Other End Users

8 Global Lactobacillus Strains Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Morinaga Milk Industry Co., Ltd.
  • 10.2 Chr. Hansen Holding A/S
  • 10.3 Danone S.A
  • 10.4 ADM (Archer-Daniels-Midland Company)
  • 10.5 Nestle S.A
  • 10.6 Koninklijke DSM N.V.
  • 10.7 International Flavors & Fragrances Inc.
  • 10.8 Arla Foods Inc
  • 10.9 Lallemand Inc.
  • 10.10 Yakult Honsha Co., Ltd.
  • 10.11 DowDuPont
  • 10.12 Chobani LLC
  • 10.13 Kerry Inc
  • 10.14 Post Holdings Inc
  • 10.15 Novozymes Inc

List of Tables

  • Table 1 Global Lactobacillus Strains Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
  • Table 4 Global Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
  • Table 5 Global Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
  • Table 6 Global Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
  • Table 7 Global Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 8 Global Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
  • Table 9 Global Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
  • Table 10 Global Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 11 Global Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 12 Global Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
  • Table 13 Global Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 14 Global Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
  • Table 15 Global Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 16 Global Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
  • Table 17 Global Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
  • Table 18 Global Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 19 Global Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 20 North America Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
  • Table 21 North America Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
  • Table 22 North America Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
  • Table 23 North America Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
  • Table 24 North America Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
  • Table 25 North America Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
  • Table 26 North America Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 27 North America Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
  • Table 28 North America Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
  • Table 29 North America Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 30 North America Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 31 North America Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
  • Table 32 North America Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 33 North America Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
  • Table 34 North America Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 35 North America Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
  • Table 36 North America Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
  • Table 37 North America Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 38 North America Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 39 Europe Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
  • Table 40 Europe Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
  • Table 41 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
  • Table 42 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
  • Table 43 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
  • Table 44 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
  • Table 45 Europe Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 46 Europe Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
  • Table 47 Europe Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
  • Table 48 Europe Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 49 Europe Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 50 Europe Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
  • Table 51 Europe Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 52 Europe Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
  • Table 53 Europe Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 54 Europe Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
  • Table 55 Europe Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
  • Table 56 Europe Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 57 Europe Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 58 Asia Pacific Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
  • Table 59 Asia Pacific Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
  • Table 60 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
  • Table 61 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
  • Table 62 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
  • Table 63 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
  • Table 64 Asia Pacific Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 65 Asia Pacific Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
  • Table 66 Asia Pacific Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
  • Table 67 Asia Pacific Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 68 Asia Pacific Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 69 Asia Pacific Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
  • Table 70 Asia Pacific Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 71 Asia Pacific Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
  • Table 72 Asia Pacific Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 73 Asia Pacific Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
  • Table 74 Asia Pacific Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
  • Table 75 Asia Pacific Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 76 Asia Pacific Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 77 South America Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
  • Table 78 South America Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
  • Table 79 South America Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
  • Table 80 South America Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
  • Table 81 South America Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
  • Table 82 South America Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
  • Table 83 South America Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 84 South America Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
  • Table 85 South America Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
  • Table 86 South America Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 87 South America Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 88 South America Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
  • Table 89 South America Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 90 South America Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
  • Table 91 South America Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 92 South America Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
  • Table 93 South America Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
  • Table 94 South America Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 95 South America Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 96 Middle East & Africa Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
  • Table 97 Middle East & Africa Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
  • Table 98 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
  • Table 99 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
  • Table 100 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
  • Table 101 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
  • Table 102 Middle East & Africa Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 103 Middle East & Africa Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
  • Table 104 Middle East & Africa Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
  • Table 105 Middle East & Africa Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 106 Middle East & Africa Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 107 Middle East & Africa Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
  • Table 108 Middle East & Africa Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 109 Middle East & Africa Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
  • Table 110 Middle East & Africa Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 111 Middle East & Africa Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
  • Table 112 Middle East & Africa Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
  • Table 113 Middle East & Africa Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 114 Middle East & Africa Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)